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SATU PENILAIAN PENGGUNAAN UBATAN SECARA
RASIONAL DALAM PENGURUSAN MALARIA DIANTARA
FASILITI KESIHATAN AWAM DAN SWASTA DI DUA
BANDAR PAKISTAN
ABSTRAK
Malaria menjadi masalah kesihatan awam berterusan yang utama di Pakistan,
disebabkan masalah sosioekonomi dan epidemiologi. Tesis ini bertujuan menilai
senario semasa tentang penggunaan drug secara rasional, pengetahuan, persepsi dan
kepatuhan terhadap preskriber-dengan garis panduan rawatan yang standard bagi
malaria di kemudahan penjagaan kesihatan awan dan swasta di dua buah
bandaraya di Pakistan, iaitu Islamabad (ibu negara Pakistan) dan Rawalpindi
(bandaraya berkembar). Gabungan kaedah  penyelidikan  kuantitatif dan  kualitatif
digunakan bagi pengumpulan data. Persepsi daripada pegawai yang terlibat
dalam program kawalan malaria, preskriber dan ahli farmasi hospital
berhubung faktor yang memberi kesan terhadap amalan rawatan malaria secara
rasional diteliti berdasarkan dapatan daripada temu bual separa–struktur. Teknik
pensampelan rawak mudah digunakan untuk memperoleh sampel kemudahan
penjagaan kesihatan awam dan swasta tertier (n = 20), sekunder (n = 10), dan primer (n = 20), dan farmasi komuniti dari Islamabad (n=118) dan Rawalpindi (n=120) masing-masing. Di samping itu, sampel 360 preskriber dipilih secara rawak dari kedua-dua bandaraya (n  = 180  di  setiap
bandaraya). Amalan  preskripsi  dinilai berdasarkan indikator preskripsi WHO,
sementara itu, soal selidik berstruktur digunakan untuk menilai persepsi dan
pengetahuan preskriber tentang garis panduan rawatan malaria yang standard.
Borang USAID (United State Agency for International Development) dan soal
selidik digunakan untuk meneliti ketersediaan dan proses pengurusan drug.
Lawatan juga dilakukan di farmasi komuniti untuk memantau pengurusan kes-kes
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penyakit malaria. Berdasarkan dapatan kajian kualitatif, secara rasminya, semua
program kawalan malaria yang  diadakan adalah berjaya. Kejayaan ini tercapai
dengan adanya peningkatan kemudahan diagnostik dan latihan dalam kalangan
preskriber di Pakistan. Namun demikian, disebabkan kekangan kewangan, kejayaan
program ini hanya tercapai  di  kawasan endemik yang tinggi,  iaitu di sembilan
belas buah daerah. Semua responden berpendapat bahawa amalan preskripsi
yang tidak rasional, pengurusan  drug yang tidak efektif, kurangnya kesedaran
dan kepatuhan pada arahan preskriber dan pengubatan-diri adalah faktor utama
yang menyumbang terhadap amalan rawatan malaria yang tidak rasional di
Pakistan.
Sementara itu, dapatan kuantitatif menunjukkan bahawa pengetahuan dan kepatuhan
terhadap arahan preskriber adalah lemah atau tidak begitu baik. Daripada 1500
preskripsi, diagnosis dinyatakan dalam 49% (n = 35) pembilang, namun ujian
parasit malaria hanyalah 7.3% (n = 110) daripada total kes. Drug anti-malaria
yang betul berdasarkan garis panduan rawatan standard dipreskrib dalam 33.8 % (n
= 507) daripada kes. Secara keseluruhan, pengetahuan preskriber tentang regimen
rawatan standard bagi malaria adalah tidak mencukupi (skor sederhana = 10). Skor
total adalah di antara 6-12, dengan skor rendah menunjukkan pengetahuan yang
baik. Kebanyakan stok drug anti-malaria ditemui di kedua-dua kemudahan
penjagaan kesihatan awam dan swasta, namun demikian, ia lebih ketara di sektor
awam. Pengurusan kes yang lemah atau tidak baik serta amalan pendispensan
berkaitan rawatan malaria di farmasi komuniti dilaporkan disebabkan
kekurangan staf yang berkualiti. Sebagai kesimpulan, tesis ini mengesahkan
wujudnya amalan rawatanyang tidak rasional bagi malaria di Pakistan. Namun
demikian, adalah sukar untuk mengubah amalan sedia ada. Walau bagaimanapun,
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intervensi pendidikan yang bersesuaian, penglibatan program kawalan malaria
secara aktif, pemegang taruh atau pemegang amanah yang berbeza, dan pelaksanaan
dasar kawalan malaria diperlukan  untuk  mencapai amalan rawatan yang rasional
dan  kawalan  malaria dalam negara.
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A STUDY EVALUATING RATIONAL DRUG USE IN MALARIA
MANAGEMENT AMONG PUBLIC AND PRIVATE HEALTHCARE
FACILITIES AT TWO PAKISTAN CITIES
ABSTRACT
Malaria continues to be a major public health issue in Pakistan, due to
socioeconomic and epidemiological reasons. The thesis aimed to assess current
scenario related to rational drug use, knowledge, perceptions and adherence of
prescribers with standard treatment guidelines for malaria in public and private
healthcare facilities in two cities of Pakistan; Islamabad (national capital) and
Rawalpindi (twin city). A combination of quantitative and qualitative research
methods were used for data collection. The perceptions’ of malaria control program
officials, prescribers and hospital pharmacists  regarding factors affecting rational
treatment  practices for malaria were explored by conducting semi-structured
interviews. Simple random sampling technique was used to draw the sample of
public and private tertiary (n = 20), secondary (n = 10), primary (n = 20) healthcare
facilities and community pharmacies from Islamabad (n = 118) and Rawalpindi
(n=120) respectively. Besides that, a sample of 360 prescribers was selected
randomly from the two cities (n = 180 each city). Prescribing practices were
evaluated by assessing prescriptions for malaria using WHO prescribing indicator
form while a structured questionnaire was used to assess the perceptions and
knowledge of prescribers regarding standard treatment guidelines. United State
Agency for International Development (USAID) stock out form and questionnaire
were use to review drug availability and process of drug management respectively.
Simulated visits were also performed to observe disease case management of
malaria at community pharmacies. Based on the results of the qualitative study,
all the malaria control  program officials agreed on successful implementation of
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the malaria control program by improving   diagnostic facilities and case
management through  training   of prescribers in Pakistan. But due to financial
constraints, this has been true only for the targeted high endemic areas of nineteen
different districts of the country by the malaria control program. All the respondents
were of the view that irrational prescribing practices, ineffective drug management,
lack of awareness and adherence of prescribers to standard treatment guidelines
and self medication are the major factors contributing towards irrational treatment
practices for malaria in Pakistan.
While the results of the quantitative findings revealed, poor knowledge and
adherence of prescribers with the standard treatment guidelines for malaria in
Pakistan. Out of 1500 prescriptions, diagnosis was mentioned in 49% (n = 735) of
the encounters but malarial parasite test was referred in only 7.3% (n = 110) of the
total cases. Correct anti-malarial drugs according to standard treatment guidelines
were prescribed in 33.8 % (n = 507) of the cases. The overall knowledge of
prescribers regarding standard treatment regimen for malaria was inadequate (median
score = 10). The total score was between 6-12 with lower scores indicating better
knowledge. Major anti-malarial drug stock outs were seen in both public and private
healthcare facilities but more prevalent in the public sector. Poor case management
and dispensing practices in relation to treatment of malaria at community
pharmacies was reported due to low availability of qualified person. In conclusion,
this thesis confirmed irrational treatment practices for malaria in Pakistan. Although,
it might be difficult to change the current practices, however, appropriate educational
interventions, active involvement of Malaria Control Program, different stakeholders
and implementation of Malaria Control Policy are required  to achieve rational
treatment practices and control of  malaria  in  the country.
1  
 
 
CHAPTER ONE 
 
 
GENERAL INTRODUCTION 
 
 
1.1  Background 
 
 
Malaria remained one of the major health challenges to be addressed in the 
developing world. Approximately over three billion people live under the threat of 
malaria globally and the disease kills more than one million people each year (World 
Health Organization, 2012). Around 1.1-1.3 million deaths due to malaria worldwide 
were reported and the incidence of malaria globally was documented between 350- 
500 million cases in 2004 (World Health Organization, 2005). Approximately 5 
million confirmed cases of malaria are reported each year from countries outside 
Africa, out of which 3 million are from India and Pakistan (World Health 
Organization, 2005). Malaria risk is often related to population movements 
particularly in the forest areas of Southeast Asia and South America where variety of 
anti-malarial drugs are used irrationally. Resistance to multiple anti-malarial drugs 
was first documented in these areas (World Health Organization, 2002b). 
 
Most of the cases of malaria are reported in the South and South Eastern Asia 
regions (Cotter et al., 2013). Approximately, 70% of the total population (1216 
million people) of South Eastern Asia Region is at risk of malaria; of which 
approximately 29% of the population is at moderate to high risk of malaria while 
71% is at low risk of malaria. More than 95% confirmed cases of malaria and deaths 
are  reported  from  population  of  moderate  to  high  risk  of  malaria  living  in 
Bangladesh,  India,  Pakistan,  Indonesia,  Myanmar  and  Thailand  (World  Health 
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Organization, 2011). The increase in malaria in these Asian countries was due to 
economic situation, migration of populations and low quality health services. The 
prevalence of malaria due to Plasmodium falciparum is rapid. The highest number 
of laboratory confirmed cases were reported from India (1,563,344)  followed by 
Indonesia (544,470) and Myanmar (414,008) where as the lowest number of cases 
was reported from Sri Lanka (558)  followed by Bhutan (972) and Nepal (3,335) 
(World Health Organization, 2011). There has been little success in malaria control 
over the last decade in Asia due to lack of funding and resistance to anti-malarial 
drugs (World Health Organization, 2005). 
 
1.2   Barriers to malaria control: A brief overview 
 
 
Malaria has always remained a major cause of mortality globally (World Health 
Organization, 2002b). Malaria can be controlled through early diagnosis and 
effective treatment. The emergence of high rates of resistance to anti-malarial drugs 
due to lack of adherence of practitioners with standard treatment regimen for malaria 
has been reported in several developing countries (Abdel Hameed, 2003, Abuaku et 
al., 2005, Chuma et al., 2009, Chandler et al., 2008b). The contribution of 
inappropriate prescribing of anti-malarial drugs on transmission of drug resistance 
highlights the need to improve malaria treatment practices (Gbotosho et al., 2009). 
Access to essential drugs should not only be seen as a component of malaria control 
but also as a fundamental right of all populations at risk of malaria (World Health 
Organization, 2006). Availability of limited number of new anti-malarial drugs and 
resistance to conventional drugs have increased difficulties in formulating anti- 
malarial treatment policies and have delayed provision of prompt and effective 
treatment  (UNICEF,  2000).  Malaria is usually over-diagnosed and anti-malarial 
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drugs  are  prescribed  empirically  to  patients  without  laboratory  confirmation  of 
malaria parasitaemia (Font et al., 2001). Most of the malaria cases are usually self- 
treated. Reasons underlying this practice include difficulty with access to health 
centre facilities, lack of affordable anti-malarial drugs, perceived deficiencies in the 
performance of formal health services including poor clinical and diagnostics skills, 
attitude of health personnel and cultural beliefs. These shortcomings encourage 
treatment of malaria at home with inappropriate drugs including herbal preparations 
purchased from pharmacy outlets (Okeke and Uzochukwu, 2009). All these concerns 
calls for in-depth investigation of the factors underling the problems in the practice 
and designing appropriate interventions addressing the causative issues in the control 
of malaria (Okeke et al., 2006). Thus strategies must be designed to achieve 
significant improvements in knowledge, behavior, compliance, performance and 
practices of prescribers/pharmacists and drug sellers in hospitals and at retail 
pharmacies  respectively,  for  promoting  rational  practices  for  the  treatment  and 
control of malaria  (Grand et al., 1999). 
 
1.3  Justification for the study 
 
 
The  rationale  for  malaria  control  is  based  on  early diagnosis  and  effective 
treatment. Treatment is specific for the type of malaria and is based on different 
phases of the parasite cycle. This leads to complex treatment regimens. Appropriate 
prescribing practices, drug management, quality of patient care services and rational 
drug use are considered as key elements for control of malaria (Meremikwu et al., 
2007, Osorio et al., 2009). Most of the high burden countries usually face financial 
constraints and lack of interest in exploring the underlying causes for the irrational 
use of drugs. Insufficient data regarding the health system performance, malaria 
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epidemiological  profile,  community  dynamics,  decision  making  and  prioritizing 
health problems have been reported. This has been particularly true about the high 
burden country for malaria, like Pakistan which is the focus of this research 
undertaking. Given the malaria control program push for the control of malaria, it is 
important to ascertain the contributing factors responsible for irrational practices for 
the treatment and control of malaria in Pakistan. Indeed, the impact of different 
aspects of performance of malaria control program at central and district levels 
remain to be fully elucidated. Furthermore, no study has yet been conducted to assess 
the perceptions of healthcare professionals regarding irrational treatment practices 
for malaria. This study was therefore designed to investigate the perceptions of 
doctors and pharmacists regarding factors underlying irrational prescribing practices 
and procurement issues of anti-malarial drugs in Pakistan. In-depth interviews were 
conducted  with  the  participants  from  each  of  these  groups  to  explore  their 
perceptions. 
 
Based on the outcomes of the interviews, further studies were undertaken to 
investigate current prescribing patterns, knowledge and adherence of prescribers with 
standard treatment regimen for malaria, drug management practices offered in 
different public and private primary, secondary and tertiary healthcare facilities and 
case  management  of  malaria  at  community  pharmacies  in  two  major  cities  of 
Pakistan. The current study will serve as baseline data for the policy makers, 
managers, researchers and other stakeholders to modify the existing interventions or 
design future interventions for improving irrational treatment practices developing 
methods of accountability and control for malaria in Pakistan. 
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1.4 Overview of thesis 
 
Chapter 2, the literature review, starts with malaria as disease and risk groups. 
A brief discussion of important features of malaria including burden, manifestation, 
symptoms, treatment and control strategies has been discussed. Monitoring trends 
and treatment policy along with changes in the policy have also been included. 
Rational  drug  use  and  barriers  related  to  workplace,  prescribing,  dispensing, 
currently available anti malarial drugs and patient are discussed in depth. The chapter 
continues  with  an  overview of different  strategies  used  for improving treatment 
practices globally. A brief discussion on the gaps identified in the current literature is 
also included in this chapter. Further discussion in this chapter involves malaria 
epidemiology, current scenario of malaria control, policy, treatment practices and 
role of malaria control program in Pakistan. A thorough review of literature relevant 
to  the study,  looking at  adherence with  standard treatment guidelines (STGs),  
resistance,  diagnosis,  prescribing practices and the views of prescribers, dispensers, 
community towards the drug use in  the  world  forms  the  bulk  of  this  chapter.  
Chapter  3  comprises  a  thorough discussion of the methodology used for the 
qualitative and quantitative studies undertaken. 
Chapters 4, 5 and 6 are consolidated as Section A of the thesis, which details 
the  findings  from  the  qualitative  interviews  with  conveniently  sampled  malaria 
control program officials, prescribers and pharmacists in Islamabad and Rawalpindi, 
Pakistan. Chapter 4 presents the findings from interviews conducted with malaria 
control program officials regarding their perceptions about the role of malaria control 
program in Pakistan. 
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Chapter  5  presents  the  findings  from  the  interviews  with  prescribers 
regarding factors related with prescribing practices for the treatment of malaria in 
Pakistan. Chapter 6 presents the findings from interviews with the hospital 
pharmacists regarding issues related to the process of drug management including 
selection, procurement, inventory control and storage. Chapters 7, 8, 9 and 10 are 
consolidated  as  Section  B  of  this  thesis,  which  describes  the  findings  from 
quantitative surveys assessing knowledge of prescribers regarding standard treatment 
guidelines, prescribing patterns and adherence to standard treatment guidelines, anti- 
malarial drugs management and case management of malaria at community 
pharmacies. 
Chapter 7 describes an analysis of the knowledge and perceptions held by the 
prescribers regarding adherence to standard treatment guidelines. Chapter 8 describes 
the findings of prescribing patterns and adherence of prescribers with standard 
treatment guidelines for the treatment of malaria among public and private primary, 
secondary  and  tertiary  healthcare  facilities.  Chapter  9  describes  findings  of  the 
process   of   anti-malarial   drug   management   including   selection,   procurement, 
inventory control and storage at public and private primary, secondary and tertiary 
healthcare facilities. Chapter 10 describes findings of case management of malaria 
including history taking and provision of advice at community pharmacies through 
simulated patients’ visits. Chapters 11 illustrate the thesis to final conclusion along 
with recommendations for further research. 
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CHAPTER TWO 
 
 
LITERATURE REVIEW 
 
 
 
 
 
2.1 Malaria as disease 
 
 
Malaria has been classified as “emerging infection” and major cause of 
morbidity and mortality in tropical and sub-tropical regions of the world (Conway, 
2007). The early discoveries of malaria have been well known. In 1880, Charles 
Louis Alphonse Laveran was the one who saw the malaria parasite for the first time. 
While Ronald Ross in 1897, discovered the complete mosquito cycle and Giovanni 
Batista in 1898, recognized the anopheles transmission of malaria in human. All 
these discoveries are the basis of currently originated malaria treatment research in 
the world (Sherman, 1998). 
 
2.2 Important features of malaria 
 
 
2.2.1 Malaria endemic vs. epidemic 
 
 
Malaria can have different appearances based on type of exposure. Malaria 
endemicity may impact disease presentation in the population (e.g., susceptibility of 
patients and percentage of febrile patients with malaria), diagnostic and treatments 
policies and procurement systems. Moreover, recent rigorous preventative measures 
are predictable to assist in shifting prevalence from endemic to epidemic 
manifestations (Cook, 1988). 
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2.2.2 Seasonality 
 
 
Malaria has seasonal fluctuations in some areas, with increased cases during 
the rainy season (Cook, 1988). 
 
2.2.3 Geography 
 
 
Usually  lower  altitude,  wetter  and  more  dense  foliage  provide  more 
hospitable environments for malaria-carrying mosquitoes. However, urban areas 
might  be  less  susceptible  of  transmission  than  rural  areas  in  different  countries 
(Cook, 1988, Silva and Marshall, 2012). 
 
2.2.4 Different species of malaria parasite 
 
 
Five species of the plasmodium parasite can infect humans: the most serious 
forms of the disease are caused by Plasmodium falciparum, and Plasmodium vivax 
which accounts for nearly all cases of malaria in humans. Malaria caused by 
Plasmodium ovale, and Plasmodium malariae produces milder disease not generally 
fatal in humans. A fifth species, Plasmodium knowlesi, causes malaria in macaques 
and can infect humans (Hsiang et al., 2010). 
 
2.2.5 Global burden of malaria caused by different species 
 
 
The global malaria incidence and malaria-speciﬁc mortality rates were 
decreased by 17% and 26% respectively, between 2000 and 2010 (World Health 
Organization, 2011, Pigott et al., 2012). Many countries such as Armenia, Morocco, 
Turkmenistan, and the United Arab Emirates have been declared as malaria free 
countries in the past five years (Yangzom et al., 2012, Cotter et al., 2013). Malaria- 
eliminating countries have contributed significantly to the reduction of the global 
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malaria burden over the past decade (Cotter et al., 2013). The total caseload of these 
specific malaria eliminating countries has been reduced by 79% in the Asia Paciﬁc 
region, 86% in Latin America, 92% in sub Saharan Africa, and 96% in the Middle 
East, Europe and central Asia. Increased funding, effective vector control, improved 
case management with more effective treatment regimens and better case reporting 
and surveillance were the main factors responsible for these successes (Cotter et al., 
2013). 
An estimated global burden of 451 million clinical cases caused by P. 
falciparum has been reported. Most of these cases occurred in India, Nigeria, The 
Democratic Republic of the Congo and Myanmar (Hay et al., 2010). The focus of 
malaria control has understandably been on P. falciparum in high endemic countries. 
Many malaria-endemic countries including all countries in Europe and central Asia, 
Argentina, Belize, Mexico, and large parts of China have been successful in 
eliminating P. falciparum from them (Gething et al., 2012). 
However, P. vivax is still the remaining challenge for the malaria eliminating 
countries  as  been  less  responsive  to  control  interventions  than  P. falciparum 
infections because of several unique features. It has a dormant liver stage that can 
result in relapses even after treatment and greater range of ecological receptivity 
unlike P. falciparum (Mueller et al., 2009). Out of the 34 malaria-eliminating 
countries, 26 of the countries have 76% of the malaria burden mainly due to P. vivax 
(Feachem et al., 2010). The global burden of malaria due to P. vivax is 70–80 million 
cases annually. Approximately 10–20% of the world’s malaria cases caused by P. 
vivax infection occur in Africa and 1% of the cases in western and central Africa. 
However, about 80–90% of P. vivax cases occur outside of Africa in the Middle East, 
Asia, Western Paciﬁc and 10 –15% in Central and South America. P. vivax infections 
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usually affect people of all ages and is rarely fatal, but can have major harmful 
effects on personal well-being, growth and development along with economic 
performance at individual, family, community, and national levels (Mendis et al., 
2001). 
 
2.2.6 Pathophysiology of malaria 
 
 
 
The plasmodium parasite that causes malaria is transmitted from mosquitos to 
men. The parasites spend part of their life cycle in the mosquito and part of it in the 
human host. The infective plasmodial sporozoites enter the bloodstream from the 
saliva of the female anopheles mosquito (White and Ho, 1992, Anstey et al., 2009). 
The sporozoites are cleared from the blood stream by the Kupfer cells of the liver, 
but few of the sporozoites manage to enter the hepatocytes. The parasites transform 
into schizonts, and after replication finally into merozites within the hepatocytes 
(White and Ho, 1992). These merozoites are then released into the bloodstream 
where they penetrate into red cells and change into ring form called trophozoites. 
Trophozoites metamorph into schizonts and produce new merozoites inside the red 
cells by using haemoglobin. The red cells eventually burst and release merozoites 
that can invade new red blood cells (White and Ho, 1992). Some of the trophozoites 
in the red cells changes into sexual form of parasite i.e. gametocytes and do no lyse 
the red blood cells (Anstey et al., 2009). These gametocytes are then acquired by the 
mosquito taking blood meal from the respective person and thus the sexual 
reproduction cycle then begins in the mosquito, and subsequently it transmits the 
parasite to other human host (White and Ho, 1992, Anstey et al., 2009) (Figure 2.1). 
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Figure 2.1 Pathophysiology of malaria 
Adapted from: Jones, M. K. & Good, M. F. (2006) 
 
 
 
2.2.7 Manifestation of malaria 
 
 
Uncomplicated malaria is the most common form and may be intermittent or 
remittent but majority of patients can live with recurrences. However, cerebral or 
complicated malaria can be lethal if not treated immediately, especially among 
compromised patients, making children more vulnerable. To prevent development of 
complicated malaria, the WHO recommends using arteminsin combination treatment 
therapy within 24 hours onset of fever (Cook, 1988). 
 
2.2.8 Malaria control strategy 
 
 
2.2.8 (a) Prevention 
 
 
Insecticide-treated bed nets and insecticide house spraying are the most 
commonly used preventive methods for malaria. A study conducted in South Africa 
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reported a significant reduction in malaria incidence in communities using treated 
bed nets than house spraying (Mnzava et al., 2001). Various studies have provided 
evidence of insecticide treated bed nets (ITBNs) special role in reducing severe 
morbidity in children under five years of age from malaria and as highly cost-
effective intervention for control of malaria in resource constraints settings 
(Wiseman et al., 2003, Nevill et al., 1996). The focus of cleanup operations from 
‘waste’ to ‘breeding sources’ including things and places that hold water in home 
based and major community based source elimination operations can also help in 
combating mosquitoes (Jamsheed, 2011). 
 
2.2.8 (b) Environmental 
 
 
 
Forest activity, abstaining from bed nets use, ethnicity, age and education are 
considered  as  risk  factors  for malaria infections.  Control  of malaria  remains  an 
extremely complex task that can only be accomplished by addressing the foremost 
risk determinants in malaria such as control of forest poverty-related risk factors 
including  education,  ethnicity  and  housing  conditions  (Thang  et  al.,  2008). The 
numbers of malaria cases were reduced significantly between 1994 and 2011 in 
Sabah state, Malaysia but still an increasing proportion of malaria cases of adult men 
were reported due to their involvement in plantation work and forest activities which 
exposed them to outdoor biting vectors (Cotter et al., 2013). Similarly, occupational 
activities such as farming, forest clearing, hunting, and wood gathering were 
associated with increased chances of malaria infection in adult men in Bhutan, India, 
Sri Lanka and Philippines (Yangzom et al., 2012, Tobgay et al., 2010, Wangdi et al., 
2011). 
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2.2.8 (c) Vector control 
 
 
 
Insecticides are one of the cheapest and most effective methods of controlling 
malaria, but mosquitoes can rapidly evolve resistance. The use of existing chemical 
insecticides, bio-pesticides, and novel chemistry and one-off investment in a single 
insecticide can solve the problem of mosquito resistance forever. However, current 
strategies for dealing with resistance evolution are expensive and their sustainability 
has yet to be demonstrated (Read et al., 2009). 
 
2.2.9 Diagnosis of malaria 
 
 
Presumptive treatment with anti malarial drugs is a common practice by the 
public and private health care workers in malaria endemic regions. This has made 
malaria incidence difficult to be measured accurately. The diagnostic policies have 
shifted from predominantly clinical to laboratory diagnosis (rapid diagnostic test 
RDT or microscopy) in the recent years. The WHO recommends prompt 
parasitological confirmation to be obtained by microscopy or RDTs before starting 
treatment of patients suspected with malaria. Treatment based solely on clinical 
suspicion should be considered only when a parasitological diagnosis is not 
accessible. Light microscopy remains the gold standard in settings where many 
patients are to be tested but in peripheral settings it is usually less feasible or cost 
effective therefore, rapid diagnostic test (RDT) and clinical diagnosis based solely on 
fever are considered best options for diagnosis of malaria in these settings. Other 
approaches, such as polymerase chain reaction (PCR) and immunological tests for 
malaria are also available but are useful only for research purposes due to their high 
cost (Hammer, 1993). 
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2.2.10 Treatment of malaria 
 
 
Development and testing of standard treatment guidelines for malaria have 
been initiated globally in various countries. Most countries are also updating their 
Integrated Management of Childhood Illness (IMCI) guidelines to align with WHO 
recommendations that confirmed diagnosis precede all treatment, even in children 
under the age of five. But still chloroquine and sulphadoxine/pyrimethamine (SP) are 
recommended as first line agents for uncomplicated malaria in several developing 
countries. SP is also used for intermittent preventive treatment in pregnancy (IPTp). 
Complicated or severe malaria is often treated with injectable artesunate or quinine 
(Acremont et al., 2009). Anti-malarial drugs are usually classified according to their 
action on the stage of the parasite cycle. Resistance has developed to several anti 
malarial drugs used as monotherapies, resulting in the current recommendation to use 
only combination therapies to treat uncomplicated malaria. Therefore, most of the 
countries have transitioned from monotherapies to Artemisinin Combination Therapy 
(ACT) as first-line treatment for uncomplicated malaria (Acremont et al., 2009). A 
detail classification of different anti-malarial drugs is given (Table 2.1). 
 
Table 2.1 Classification of different anti-malarial drugs* 
 
 
Therapeutic Class Anti-malarial Drugs Mode of Action 
Prophylactic Drugs Proguanil/Atovaquone, Pyrimethamine, 
Doxycycline, Mefloquine 
 
Schizontocidal Drugs Quinine,Mepacrine,Chloroquine, 
Amodiaquine, Arteminsins deravatives 
Active against primary tissue 
schizontocides of P.vivax and 
P.falciparum 
Acts on asexual erythrocytic 
form of all parasites 
Gametocytocidal Drugs Pamaquine, Primaquine, Plasmocide Acts on asexual form of all 
malaria parasite especially 
P.vivax & P.malariae 
Sporontocidal Drugs Quinocide, Proguanil, Chloroproguanil, 
Pyrimethamine/ sulphadoxine 
Inhibits sporogenic phase of 
P.vivax & P. falciparum 
Anti relapse Drugs Pamaquine, Primaquine, Quinocide Acts on secondary 
exo-erythrocytic phase of 
P.viax & P.malariae 
      * Directorate of Malaria Control and WHO, National Treatment Guidelines for Malaria. 2006 
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2.3 Risk groups for malaria 
 
 
2.3.1 Burden of malaria in pregnancy 
 
 
Approximately, 75,000 to 200,000 infant deaths are associated with malaria 
infection in pregnancy every year, globally. Low birth weight (LBW) from 
prematurity and intrauterine growth retardation (IUGR) is the major determinants of 
infant mortality in malaria. Malaria-induced LBW kills 62,000–363,000 newborns 
annually.  These  malaria-induced  medical  problems  poses  major  clinical,  public 
health and research challenges which may contribute to increase mortality rate 
(Murphy and  Breman,  2001). The  failure of effective anti-malarial interventions 
through   antenatal   programs   is   significantly   contributing   to   infant   mortality 
worldwide. Less than 20% of the women use prophylactic regimen as per WHO 
recommendations in pregnancy which is due to low access and quality of antenatal 
care (ANC) services (TerKuile et al., 2003, Steketee et al., 2001, Menendez et al., 
2007). 
 
2.3.2 Child mortality in malaria 
 
 
Approximately one million children under the age of five years die each year 
due  to  malaria  globally,  out  of  which  75  %  are  from  Africa  (Crawley,  2004). 
Anaemia usually affects more than half of all pregnant women and children less than 
five years old, and has serious consequences associated with an increased risk of 
death. Effective management of malaria in children under the age of 5 requires 
mothers to seek appropriate information regarding proper use of anti-malarial drugs. 
This is linked to timely decision, accessibility, correct use of the drugs and follow-up 
(Malik et al., 2006). Despite the magnitude of the problem of child mortality and 
constantly  increasing  research  findings  related  to  pathogenesis,  risk  factors  and 
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efficacious interventions, child mortality in malaria-endemic countries still remains 
poor. This might be due to rapid spread of resistance to anti-malarial drugs, coupled 
with widespread poverty, weak health infrastructure and failure of currently available 
interventions to address child mortality from malaria (Singer and Teklahaimanot, 
2003, Crawley, 2004). 
 
 
 
2.4 Monitoring trends for malaria control 
 
 
 
Mortality has always been considered as the primary indicator of a serious 
problem especially in vulnerable groups in malaria. Data from health facilities is a 
useful tool for monitoring trends in morbidity and mortality as well as the impact of 
control measures  and other factors that affect  malaria  (United State Agency for 
International Development, 2011). But various limitations are seen while monitoring 
of malaria control. Reporting varies in its quality, comprehensiveness and 
appropriateness which might be due to lack of an accountable health information 
system or interest of concerned respective authorities in updating the data base in 
different developing countries. Data from non-governmental facilities or from the 
community where most cases of malaria illness and deaths occur is scarce. Thus, 
these factors contribute towards difficulties in developing standardized case 
definitions for malaria morbidity and mortality (UNICEF, 2000). 
 
2.5 Treatment policy for malaria 
 
 
It is the responsibility of national health programs to develop a treatment 
policy for malaria which should ideally be part of the national malaria control policy, 
covering prevention as well as case management (World Health Organization, 2005). 
Given the importance of the issues, the anti-malarial drug policy should be given 
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prominence within and supported by the National Drug policy (NDP) and National 
Malaria Control Policy (NMCP). The NMCP and the NDP should conform to the 
overall National Health Policy. It is recognized that anti-malarial treatment policies 
usually vary between countries depending on the epidemiology of the disease, 
transmission, patterns of drug resistance and political and economic contexts. In 
addition, significant variations in the therapeutic response to first-line anti-malarial 
drugs may exist in different geographical localities and regions of a country. 
Treatment  policies  in  some  countries  have  attempted  to  differentiate  between 
localities with varying drug resistance (Worrall et al., 2005). Such decisions depend 
on whether countries are able to implement different drug policies for different 
regions and whether the health system can deliver the required drug successfully to 
end-users (World Health Organization, 2005). 
 
As the available drugs become more expensive or less safe, dual policies for 
vulnerable and less vulnerable groups may need to be considered. One key challenge 
facing the development of anti-malarial treatment policies is achieving a balance 
between two essential purposes that: 
 
• All  populations  at  risk  have  access  to  prompt  treatment  with  safe,  good 
quality, effective, affordable and acceptable anti-malarial drugs. 
 
• The approach should encourage rational drug use of currently available anti- 
malarial drugs in order to avoid unnecessary selection pressure favouring the 
development of drug resistance. 
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2.6 Changes in malaria treatment policy 
 
 
The change in malaria control policy in various countries in favours of ACT 
became necessary with the prevalence of P. falciparum resistance to chloroquine 
and sulphadoxine-pyrimethamine (Snow et al., 2006). Prescription practices have 
been shown to influence the emergence of resistance to anti-malarial drugs, thus the 
success of a new treatment policy would depend on the adherence of health providers 
and patients to treatment recommendations (Noranate et al., 2007). Several ACT 
drugs exist and others are in the pipeline and have the potential to reduce mortality 
from malaria substantially if properly targeted to the right people. Current evidence 
suggests that most of those who need the drugs do not get them while a high 
proportion of those who are given anti-malarial drugs in fact do not have malaria. 
Such irrational use of ACT could undermine the goal of combination therapy, which 
is to prevent the emergence of resistant against malaria parasites (Gbotosho et al., 
2009). Financial and low accessibility to formal healthcare undermines the impact of 
provision of free anti- malarial drugs via this route. The higher cost of ACT creates a 
market for fake drugs (Whitty et al., 2008). Reliable data of the process of malaria 
treatment policy change are  urgently  required  to  address  these  issues  to  
determine  commonalities  and optimize the efficiency of formulating and 
implementing malaria treatment policy changes in different countries (Durrheim et 
al., 2003). 
 
2.7 Rational drug use, a component of good health care system 
 
 
An efficient health care system can be achieved by promotion of rational drug 
use. Rational use of drugs necessitate that patients receive ‘medicines appropriate to 
their clinical needs, in doses that meet their own individual requirements, for an 
19  
adequate period of time and at the lowest cost to them and their community’ (World 
Health  Organization,  2005). Development  of resistance to  antibiotics,  ineffective 
treatment, adverse effects, drug dependence and economic burden to the patient and 
society  are  the  major  dilemma  of  present  medical  practice  in  case  of  malaria 
(Juncosa, 2008). Enormous resources  are reported to be wasted when  drugs are 
prescribed, dispensed, administered and used in irrational way  (Quick et al., 1991). 
 
2.8 Different barriers to rational drug use in treating malaria 
 
 
The major factors which contribute to irrational drug use and affects quality 
of health  care system  are combination  of factors  including  patients,  prescribers, 
dispensers, the workplace, the supply system, influences by the pharmaceutical 
industry, regulations, drug information and misinformation (Holloway, 2006, 
Maxwell, 2009). 
 
2.8.1 Workplace 
 
 
2.8.1 (a) Lack of availability and use of diagnostic tools 
 
 
The use of microscopy and rapid diagnostic tests (RDTs) for malaria could 
improve the management of both malaria and other febrile illness. When diagnostic 
facilities are available, half or more of those with negative test results are still treated 
for malaria however, the proportion is even higher when these facilities are  not 
present (Hamer et al., 2007, Reyburn et al., 2004, Zurovac et al., 2007). Diagnosis of 
malaria in the absence of microscopic confirmation was associated with significantly 
increased mortality in hospitalized patients in Uganda (Opoka et al., 2008). The need 
of employing trained technicians who are able to differentiate between different 
plasmodium species, constant supply of reagents and equipments is usually ignored 
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(Jonkman et al., 1995, Lubell et al., 2008). The quality of slides and stains is often 
poor and current tests being used are not heat stable (Chiodini et al., 2007).  Various 
studies reported low use of diagnostic tools and poor quality blood smear staining 
leading to unreliable measurement of sensitivity and specificity and undermine the 
use of effective anti-malarial treatment (Morrow et al., 2008, Uzochukwu et al., 
2010). However, directing resources towards improving diagnostic and treatment 
practices may provide a cost-effective measure for promoting rational use of anti- 
malarial therapy (Njama et al., 2007). 
 
2.8.1 (b) Lack of availability and adherence to malaria diagnostics guidelines 
 
 
Improving the accuracy of malaria diagnosis with rapid antigen-detection 
diagnostic tests (RDTs) has been proposed as a useful approach for reducing 
overtreatment  of  malaria  in  the  current  era.  The  reasons  clinicians  respond 
irrationally to diagnostic tests are complex and may be difficult or slow to change. 
Despite efforts to expand the provision of malaria diagnostics, they are underused 
and patients with negative test results frequently receive anti-malarials. This might 
be due to lack of availability of explicit diagnostic guidelines; training of technicians 
on these guidelines; feedback systems for results of quality control of RDTs and their 
use in routine practice are the missing components in the healthcare system (Hamer 
et al., 2007, Chandler et al., 2010). 
 
2.8.2 Prescribing issues 
 
2.8.2 (a) Inappropriate diagnosis of malaria by prescribers 
 
 
Malaria is usually over-diagnosed at both healthcare centres and hospitals. 
Over diagnosis of malaria in the routine outpatient care system as compared to RDT 
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confirmed  cases  of  malaria  has  been  reported  higher  in  developing  countries 
(Reyburn et al., 2004, Mosha et al., 2010). More accurate diagnosis and management 
of febrile illnesses is significantly required, however, use of RDTs has shown 
improved health outcomes without increased cost per patient (Sievers et al., 2008, 
Rodrigues et al., 2008, Msellem et al., 2009, Okeke and Uzochukwu, 2009). 
 
2.8.2 (b) Inappropriate case management of malaria 
 
Appropriate case management of malaria is an important strategy to control 
malaria. Usually, the patients are not aware of the disease symptoms and even if 
familiar with malaria, they may ﬁnd it difficult to identify fever pattern, especially 
when  it  is  relatively low,  as  a  result,  several  patients  are  missed  for  treatment 
(Ceesay et al., 2008, Diallo et al., 2006). Patients seek treatment from variety of 
sources including traditional healers, pharmacies retail outlets and public or private 
healthcare facilities. Self-treatment is regarded as one of the major factors that leads 
to delayed and poor diagnosis of malaria (Combie, 2002). On the other hand, patients 
with malaria are often treated empirically in the healthcare facilities without any 
laboratory investigation (Chandler et al., 2008a). As substantial overlap exists in 
clinical symptoms of malaria with several other diseases which can lead to incorrect 
diagnosis (Bojang et al., 2000). Non-availability of prescribed drugs at healthcare 
facilities is also one of the common factors relating to improper case management 
(Mumba et al., 2003). Various gaps such as lack of availability of ACTs, technical 
diagnostic skills and adherence to standard treatment regimen for malaria were 
reported in Sudan (Abdelgader et al., 2012). Parasitological diagnosis of malaria at 
all levels of the healthcare system was highlighted to be the part of the malaria case 
management policy in Sudan. Case management of malaria was more appropriate in 
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the private healthcare facilities as compared to public facilities of Sudan, as health 
workers from the private sector had extensive training in malaria case-management 
(Elmardi et al., 2011). Significant improvements in malaria case management were 
reported due to implementation of new treatment policies for malaria in Zambia 
(Zurovac et al., 2007). 
 
2.8.2 (c) Prescribing patterns for malaria treatment 
 
 
Major prescribing problems due to polypharmacy and irrational use of 
antibiotics  and  injections  have  been  reported  in  various  developing  countries. 
Malaria treatments varied, but there were not large differences among the practice of 
public and private healthcare facilities (Ogwal et al., 2004). Most of the prescribers 
in developing countries usually   prescribe monotherapy, either  chloroquine, 
sulphadoxine-pyrimethamine or artemisinin derivatives alone. However, artemisinin 
combination treatments are prescribed only in few of the cases (Abuaku et al., 2005). 
Poor standards of prescribing of anti-malarial drugs, in terms of overprescribing of 
chloroquine tablets, broad spectrum antibiotics and incorrect regimens for 
intravenous administration of quinine have been reported (Kamat, 2009). Most of the 
medical practitioners tends to follow their own regimens to treat malaria in most of 
the developing countries (Yousif and Adeel, 2000). General practitioners who had 
attended less than two in-service training sessions in the past year have been reported 
to prescribe anti-malarial drugs and antibiotics without laboratory confirmation more 
frequently  (Chandler et al., 2008a, Ogwal et al., 2004). Poor compliance of patients 
to their medication due to the absence of physicians and lack of oral/written 
counselling at primary healthcare facilities was highlighted in Brazil (Suarez et al., 
2011). 
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2.8.2 (d) Availability and updating of standard treatment guidelines for malaria 
 
 
Standard treatment guidelines (STGs) are the protocols for the most effective 
treatment of a specific clinical problem in a given setting, which is based on the 
consent of experts. STGs are developed on the most effective treatment which is also 
available at low cost. If healthcare providers adhere with STG, drugs demand is more 
predictable, facilitating more accurate forecasts and constant supply of drugs at 
healthcare facilities. The major issues highlighted for drug stock-outs in Sudan were 
lack of availability of STG’s  for  malaria  in  healthcare  facilities,  continuous  
supervision,  training  and follow up of the guidelines and negative attitudes of 
hospital specialists towards the protocol following monitoring and updating of STGs. 
However, introducing STGs in pre-service training; thorough distribution of these 
guidelines to health workers, with close follow-up and supervision can improve 
prescribing practices for malaria (Ahmed and Yousif, 2004). 
 
2.8.2 (e) Lack of knowledge and adherence of prescribers to malarial STGs 
 
 
Influence of peers, pressure to conform with perceived patient preferences 
and quality of diagnostic support, involving resource management, personal 
motivations and lack of supervision are usually highlighted as the major reasons for 
lack of adherence of prescribers to STGs (Chandler et al., 2008b). Monitoring of 
drug advertising and promotional activities in the healthcare facilities by the hospital 
management can also improve compliance of prescribers with standard treatment 
guidelines (Chedi et al., 2010). 
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Intermittent Preventive Treatment of malaria in pregnancy (IPTp) is effective 
in  preventing  malaria  in  pregnancy  but  poor  knowledge  and  compliance  of 
prescribers with standard treatment guidelines was observed in Nigeria (Arulogun 
and Okereke, 2012). However, lack of adherence to national treatment guidelines, 
especially in the private sector, and a relationship between prescription practices and 
increase in anti-malarial drug resistance in Nigeria was reported (Gbotosho et al., 
2009). 
 
 
Prescribing practices of inappropriate doses of chloroquine due to lack of 
adherence  of  prescribers  with  standard  treatment  guidelines  was  found  more 
prevalent in private than public health care facilities in Ghana (Abuaku et al., 2005). 
Similar situation was reported in India, where many practitioners were not legally 
qualified and majority of them adopted diagnostic and treatment practices that were 
not consistent with the guidelines of WHO and India’s National Malaria Eradication 
Program. Medical journals were the most common source of information used by 
these practitioners. Improvement in access to information about new guidelines 
through IEC (information education communication) techniques or workshops was 
emphasized (Kamat, 2009). 
 
A systematic organized education program for adherence to STGs with 
repeated feedback meetings showed improved performance of prescribers at 
healthcare facilities in Lao PDR. Thus, the audit–feedback model can be used and 
integrated into routine work, in order to improve the clinical performance of 
prescribers at healthcare facilities (Wahlstrom et al., 2003). 
